About 36,000 results
Open links in new tab
  1. Cytotoxic T-lymphocyte associated protein 4 - Wikipedia

    Cytotoxic T-lymphocyte associated protein 4, (CTLA-4) also known as CD152 (cluster of differentiation 152), is a protein receptor that functions as an immune checkpoint and downregulates immune …

  2. Current understanding of CTLA-4: from mechanism to autoimmune ...

    Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is majorly expressed in activated T cells and works as a critical regulator in the inflammatory response.

  3. A next-generation anti-CTLA-4 probody mitigates toxicity and ...

    Oct 10, 2025 · CTLA-4 is a promising target for immune checkpoint inhibition in cancer therapy, with CTLA-4 blockade achieving prolonged overall survival for responding patients.

  4. CTLA-4: From mechanism to autoimmune therapy

    Mar 1, 2020 · We present recent advances in CTLA-4 in regulating T-cell tolerance and autoimmunity. The structure and expression of CTLA-4, its mediated signaling and role in autoimmunity reviewed. …

  5. Definition of CTLA-4 - NCI Dictionary of Cancer Terms - NCI

    A protein found on T cells (a type of immune cell) that helps keep the body’s immune responses in check. When CTLA-4 is bound to another protein called B7, it helps keep T cells from killing other …

  6. What Is CTLA-4 and How Does It Fight Cancer? - Biology Insights

    Jul 22, 2025 · CTLA-4, or Cytotoxic T-lymphocyte-associated protein 4, is a protein receptor found on the surface of T-cells. T-cells are specialized white blood cells, key components of the immune …

  7. CTLA-4: Immunotherapy Inhibitor Drugs

    Aug 1, 2024 · Anti-cancer or immunotherapy drugs called immune checkpoint inhibitors are designed to prevent T-cells from partnering with proteins that turn them off. One type of immunotherapy drug that …